| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |